Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

C O N M E D Cp (CNMD)

C O N M E D Cp (CNMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
LH vs. CNMD: Which Stock Is the Better Value Option?

LH vs. CNMD: Which Stock Is the Better Value Option?

LH : 173.24 (-0.99%)
CNMD : 84.29 (-2.32%)
37.0% Return Seen to Date on SmarTrend Conmed Corp Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 7 months, Conmed Corp has returned 36.98% as of today's recent price of $86.42.

CNMD : 84.29 (-2.32%)
Conmed Corp Up 37.3% Since SmarTrend Uptrend Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.30% as of today's recent price of $86.62.

CNMD : 84.29 (-2.32%)
Here's Why You Should Invest in CONMED (CNMD) Stock Now

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D.

OXFD : 13.13 (+0.23%)
BIO : 315.18 (+1.65%)
HAE : 121.95 (-0.76%)
CNMD : 84.29 (-2.32%)
Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues

Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.

MYGN : 28.51 (+6.86%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Medtronic's Titan Spine Buyout to Boost Spine Surgery Range

Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.

PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
MDT : 100.80 (-0.53%)
CNMD : 84.29 (-2.32%)
Walgreens Gains on Strategic Deals, Margin Pressure Remains

Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.

WBA : 54.44 (-0.69%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics

The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.

TMO : 289.82 (-1.33%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Here's Why You Should Hold Varian Medical (VAR) Stock Now

Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.

VAR : 132.80 (-1.89%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Conmed Corp Up 37.2% Since SmarTrend Uptrend Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.22% as of today's recent price of $86.57.

CNMD : 84.29 (-2.32%)
Amedisys Rides on New Buyouts, Strength in Personal Care Arm

Amedisys' (AMED) recently-integrated Personal Care segment is attaining stability and living up to expectation.

AMED : 127.75 (+0.15%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Veeva's Vault eTMF Implemented by South Korea's Celltrion

Management at Veeva (VEEV) expects Vault subscription revenues to grow a significant 40% in fiscal 2020.

VEEV : 169.49 (-2.13%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Patterson Companies' (PDCO) Earnings Miss Estimates in Q4

Patterson Companies' (PDCO) Q4 results benefit from higher revenues, gross margin expansion and solid show by Animal Health segment.

PDCO : 20.28 (-1.55%)
BAX : 83.10 (+0.02%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Varian (VAR) & Tennessee Oncology to Implement Use of Noona

Varian's (VAR) core Oncology unit gets a boost from the latest collaboration with Tennessee Oncology.

VAR : 132.80 (-1.89%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now

DENTSPLY (XRAY) focuses on innovation through active R&D.

VEEV : 169.49 (-2.13%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Veeva's Submissions & RIM Implemented by Sumitomo Dainippon

Veeva's (VEEV) flagship Vault platform witnesses robust demand.

VEEV : 169.49 (-2.13%)
PEN : 176.14 (-0.41%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Here's Why You Should Buy Masimo (MASI) Stock Right Now

Masimo (MASI) receives FDA clearance for its O3 Regional Oximetry for utilization on neonatal and infant patients.

PEN : 176.14 (-0.41%)
MASI : 153.40 (-0.51%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Conmed Corp Has Returned 36.5% Since SmarTrend Recommendation (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 36.47% as of today's recent price of $86.10.

CNMD : 84.29 (-2.32%)
Cooper Companies (COO) Q2 Earnings & Revenues Top Estimates

Higher revenues, solid segmental performance and expansion in margins benefit Cooper Companies' (COO) Q2 earnings.

COO : 331.52 (-0.12%)
MASI : 153.40 (-0.51%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)
Veeva Systems (VEEV) Q1 Earnings Top Estimates, View Strong

Veeva Systems (VEEV) issues strong guidance for fiscal 2020.

VEEV : 169.49 (-2.13%)
MASI : 153.40 (-0.51%)
XRAY : 56.67 (-0.58%)
CNMD : 84.29 (-2.32%)

Van Meerten Stock Picks

Leading Economic Indicator ALERT!
I very closely follow the Conference Board's Leading Economic Indicators.
IVV -1.75
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar